OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Substance Abuse Treatment is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Substance use disorders among older populations: What role do race and ethnicity play in treatment and completion?	137
Augmenting substance use treatment in the drug court: A pilot randomized trial of peer recovery support	89
Community perspectives on supervised consumption sites: Insights from four U.S. counties deeply affected by opioids	79
Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study	58
JSAT call for papers for special issue: Stimulant use disorder	57
Hepatitis C treatment outcomes among patients treated in co-located primary care and addiction treatment settings	56
The new services that opioid treatment programs have adopted in response to COVID-19	55
The impact of military sexual trauma and gender on receipt of evidence-based medication treatment among veterans with opioid use disorder	55
Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail	53
Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data	52
Sex-based differences in psychiatric symptoms and opioid abstinence during buprenorphine/naloxone treatment in adolescents with opioid use disorders	51
C2: editorial board	50
Life satisfaction among individuals with opioid use disorder receiving extended-release naltrexone: A 12-week randomized controlled trial and a 36-week follow-up	49
A qualitative study of service engagement and unmet needs among unstably housed people who inject drugs in Massachusetts	48
Experiences of stigma among individuals in recovery from opioid use disorder in a rural setting: A qualitative analysis	41
Education and careers were our way out	37
Serial mediation analysis of treatment-specific processes in two contrasting alcohol treatments	34
Emergency department interventions for opioid use disorder: A synthesis of emerging models	33
C2: editorial board	33
What is success in treatment for opioid use disorder? Perspectives of physicians and patients in primary care settings	33
What is the relapse risk during treatment? Survivor analysis of single and multiple relapse events in inpatients with alcohol use disorder as part of an observational study	32
Al-Anon Intensive Referral (AIR): A qualitative formative evaluation for implementation	31
Targeting women veteran's stress-induced drinking with cognitive reappraisal: Mechanisms and moderators of change	30
Facing the future of substance use disorders treatment in Vietnam – A case study for international development and cooperation	30
Can nicotine replacement therapy be personalized? A statistical learning analysis	30

Adapting methadone inductions to the fentanyl era	30
Incarceration and compulsory rehabilitation impede use of medication for opioid use disorder and HIV care engagement in Vietnam	30
Suboptimal nonmedical qualities of primary care linked with care avoidance among people who use drugs in a Canadian setting amid an integrated health care reform	27
A randomized clinical trial evaluating the impact of counselor training and patient feedback on substance use disorder patients' sexual risk behavior	27
Associations of retention on buprenorphine for opioid use disorder with patient characteristics and models of care in the primary care setting	27
Connecting and disconnecting: Experiences of people with opioid use disorder in intensive outpatient treatment	26
Improving geographic access to methadone clinics	26
Association between industry sponsorship and author conflicts of interest with outcomes of systematic reviews and meta-analyses of interventions for opioid use disorder	26
National trends in substance use treatment admissions for opioid use disorder among adults experiencing homelessness	25
Frequency and recency of non-medical opioid use and death due to overdose or suicide among individuals assessed for risky substance use: A national registry study in Sweden	25
Using machine learning to examine predictors of treatment goal change among individuals seeking treatment for alcohol use disorder	25
Drug court utilization of medications for opioid use disorder in high opioid mortality communities	25
Addressing adolescent substance use in an urban pediatric federally qualified health center	25
Tobacco smoking and nicotine dependence among patients with respiratory diseases in Vietnam: Status and correlated factors	25
The impact of social network dynamics on engagement in drug use reduction programs among men and women who use drugs	24
A randomized clinical trial of strengths-based case management to link emergency department patients to opioid use disorder treatment	24
Mobile-based brief interventions targeting cannabis-impaired driving among youth: A Delphi study	24
Latent class analysis of self-reported substance use during incarceration: Gender differences and associations with emotional distress and aggressiveness	23
The impact of COVID-19 on substance use disorder treatment in California: Service providers' perspectives	23
Knowledge, attitudes, and behaviors related to the fentanyl-adulterated drug supply among people who use drugs in Oregon	23
C2: editorial board	22
An exploration of thriving over time in recovery	22
Scoping review of interventions to link individuals to substance use services at discharge from jail	22
Adapting and scaling a single site DEA X-waiver training program to a statewide initiative: Implementing GetWaiveredTX	22
Engagement patterns with a digital therapeutic for substance use disorders: Correlations with abstinence outcomes	22
Development and validation of a claim-based provider-level measurement of use of medications to treat opioid use disorder	22
Contingency management for treatment attendance: A meta-analysis	21
The impact of COVID-19 on health care professionals who are exposed to drug-related deaths while supporting clients experiencing addiction	21
Racial disparities in linkage to care among patients with substance use disorders	21
Associations between prescription and illicit stimulant and opioid use in the United States, 2015–2020	20
Implementation of buprenorphine initiation and warm handoff protocols in emergency departments: A qualitative study of Pennsylvania hospitals	20
Associations between patient experience and clinical outcomes in substance use disorder clinics: Findings from the veterans outcomes assessment survey	20
Emotion dysregulation and hazardous drinking in relation to suicidal ideation among Spanish-speaking Latinx daily-smokers	20
Patterns of enrollment in a New Orleans women's substance use rehabilitation center	20
C2: editorial board	20
SMART Recovery International and COVID-19: Expanding the reach of mutual support through online groups	19
Corrigendum to “Feasibility and acceptability of mindful recovery opioid use care continuum (M-ROCC): A concurrent mixed methods study” [Journal of Substance Abuse Treatment 130 (2021) 108415]	19
Recidivism prevention for impaired driving: Longitudinal 5-year outcomes from Quebec's severity-based intervention assignment program	19
Beyond harm-producing versus harm-reducing: A qualitative meta-synthesis of people who use drugs' perspectives of and experiences with the extramedical use and diversion of buprenorphine	19
TOC (update)	19
Where did the specialty behavioral health workforce grow between 2011 and 2019? Evidence from census data	19
Buprenorphine use and disparities in access among emergency department patients with opioid use disorder: A cross-sectional study	19
Developing a cascade of care for opioid use disorder among individuals in jail	18
Cognitive insight, medication adherence and methamphetamine cessation in people enrolled in a pharmacotherapy trial for methamphetamine use	18
Mobile low-threshold buprenorphine integrated with infectious disease services	18
C2: editorial board	18
Alcohol and drug use among bartenders: An at risk population?	18
Value of family involvement in substance use disorder treatment: Aligning clinical and financing priorities	17
Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19	17
C2: editorial board	17

Comparison of self-reported substance use with biological testing among treatment-seeking patients with opioid use disorder	17
Follow-up after ED visits for opioid use disorder: Do they reduce future overdoses?	17
Associations between relationship quality and treatment-related stress among couples receiving methadone for opioid use disorder	16
Prescribing buprenorphine for opioid use disorder in primary care: A survey of French general practitioners in the Sentinelles network	16
Consumer access to buprenorphine and methadone in certified community behavioral health centers: A secret shopper study	16
Client attitudes toward virtual treatment court	16
TOC (update)	16
Patient-centered primary care and receipt of evidence-based alcohol-related care in the national Veterans Health Administration	16
The effect of nicotine dependence and withdrawal symptoms on use of nicotine replacement therapy: Secondary analysis of a randomized controlled trial in primary care	16
Predictive validity of the New York State Level of Care for Alcohol and Drug Treatment Referral (LOCADTR) for continuous engagement in treatment among individuals recommended for outpatient care	16
The short-term effectiveness of real-time video counselling on smoking cessation among residents in rural and remote areas: An interim analysis of a randomised trial	16